These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


171 related items for PubMed ID: 17911445

  • 1. Efficacy and safety of intravenous immunoglobulin in patients with metastatic melanoma.
    Schachter J, Katz U, Mahrer A, Barak D, David LZ, Nusbacher J, Shoenfeld Y.
    Ann N Y Acad Sci; 2007 Sep; 1110():305-14. PubMed ID: 17911445
    [Abstract] [Full Text] [Related]

  • 2. A pilot study with vincristine sulfate liposome infusion in patients with metastatic melanoma.
    Bedikian AY, Papadopoulos NE, Kim KB, Vardeleon A, Smith T, Lu B, Deitcher SR.
    Melanoma Res; 2008 Dec; 18(6):400-4. PubMed ID: 19011511
    [Abstract] [Full Text] [Related]

  • 3. Long term safety of IVIg therapy in multiple sclerosis: 10 years experience.
    Katz U, Kishner I, Magalashvili D, Shoenfeld Y, Achiron A.
    Autoimmunity; 2006 Sep; 39(6):513-7. PubMed ID: 17060031
    [Abstract] [Full Text] [Related]

  • 4. Frequency of adverse events associated with intravenous immunoglobulin therapy in patients with pemphigus or pemphigoid.
    Gürcan HM, Ahmed AR.
    Ann Pharmacother; 2007 Oct; 41(10):1604-10. PubMed ID: 17785614
    [Abstract] [Full Text] [Related]

  • 5. Intravenous immunoglobulin in relapsing-remitting multiple sclerosis: a dose-finding trial.
    Fazekas F, Lublin FD, Li D, Freedman MS, Hartung HP, Rieckmann P, Sørensen PS, Maas-Enriquez M, Sommerauer B, Hanna K, PRIVIG Study Group, UBC MS/MRI Research Group.
    Neurology; 2008 Jul 22; 71(4):265-71. PubMed ID: 18645164
    [Abstract] [Full Text] [Related]

  • 6. Phase II study of biweekly plitidepsin as second-line therapy in patients with advanced malignant melanoma.
    Eisen T, Thomas J, Miller WH, Gore M, Wolter P, Kavan P, Martín JA, Lardelli P.
    Melanoma Res; 2009 Jun 22; 19(3):185-92. PubMed ID: 19436178
    [Abstract] [Full Text] [Related]

  • 7. Treatment of chronic progressive multiple sclerosis with intravenous immunoglobulins--interim results on drug safety of an ongoing study. IVIG study group.
    Poehlau D.
    Mult Scler; 2000 Oct 22; 6 Suppl 2():S21-3. PubMed ID: 11188774
    [Abstract] [Full Text] [Related]

  • 8. Phase II trial of dacarbazine and thalidomide for the treatment of metastatic melanoma.
    Ott PA, Chang JL, Oratz R, Jones A, Farrell K, Muggia F, Pavlick AC.
    Chemotherapy; 2009 Oct 22; 55(4):221-7. PubMed ID: 19451711
    [Abstract] [Full Text] [Related]

  • 9. Phase I study of recombinant interleukin-21 in patients with metastatic melanoma and renal cell carcinoma.
    Thompson JA, Curti BD, Redman BG, Bhatia S, Weber JS, Agarwala SS, Sievers EL, Hughes SD, DeVries TA, Hausman DF.
    J Clin Oncol; 2008 Apr 20; 26(12):2034-9. PubMed ID: 18347008
    [Abstract] [Full Text] [Related]

  • 10. Combination therapy of intravenous immunoglobulin and corticosteroid in the treatment of toxic epidermal necrolysis and Stevens-Johnson syndrome: a retrospective comparative study in China.
    Yang Y, Xu J, Li F, Zhu X.
    Int J Dermatol; 2009 Oct 20; 48(10):1122-8. PubMed ID: 19775409
    [Abstract] [Full Text] [Related]

  • 11. Post-marketing observational study on 5% intravenous immunoglobulin therapy in patients with secondary immunodeficiency and recurrent serious bacterial infections.
    Günther G, Dreger B.
    Microbiol Immunol; 2013 Jul 20; 57(7):527-35. PubMed ID: 23607863
    [Abstract] [Full Text] [Related]

  • 12. Pulsed intravenous immunoglobulin therapy in livedoid vasculitis: an open trial evaluating 9 consecutive patients.
    Kreuter A, Gambichler T, Breuckmann F, Bechara FG, Rotterdam S, Stücker M, Altmeyer P.
    J Am Acad Dermatol; 2004 Oct 20; 51(4):574-9. PubMed ID: 15389193
    [Abstract] [Full Text] [Related]

  • 13. [Personal experience with replacement therapy with intravenous gamma globulin].
    Litzman J, Lokaj J, Stikarovská D, Mayer J, Thon V, Eibl MM.
    Vnitr Lek; 1995 Nov 20; 41(11):759-63. PubMed ID: 8553594
    [Abstract] [Full Text] [Related]

  • 14. Cost of intravenous immunoglobulin therapy versus conventional immunosuppressive therapy in patients with mucous membrane pemphigoid: a preliminary study.
    Daoud Y, Amin KG, Mohan K, Ahmed AR.
    Ann Pharmacother; 2005 Dec 20; 39(12):2003-8. PubMed ID: 16264064
    [Abstract] [Full Text] [Related]

  • 15. IVIG treatment for myasthenia gravis: effectiveness, limitations, and novel therapeutic strategies.
    Zinman L, Bril V.
    Ann N Y Acad Sci; 2008 Dec 20; 1132():264-70. PubMed ID: 18567877
    [Abstract] [Full Text] [Related]

  • 16. Prognostic factors in metastatic melanoma patients treated with biochemotherapy and maintenance immunotherapy.
    Minor DR, Moore D, Kim C, Kashani-Sabet M, Venna SS, Wang W, Boasberg P, O'Day S.
    Oncologist; 2009 Oct 20; 14(10):995-1002. PubMed ID: 19776094
    [Abstract] [Full Text] [Related]

  • 17. Adjuvant treatment with vindesine in comparison to observation alone in patients with metastasized melanoma after complete metastasectomy: a randomized multicenter trial of the German Dermatologic Cooperative Oncology Group.
    Eigentler TK, Radny P, Hauschild A, Gutzmer R, Linse R, Pföhler C, Wagner SN, Schadendorf D, Ellwanger U, Garbe C, German Dermatologic Cooperative Oncology Group.
    Melanoma Res; 2008 Oct 20; 18(5):353-8. PubMed ID: 18781134
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Prospective, noncomparative open study from Kuwait of the role of intravenous immunoglobulin in the treatment of toxic epidermal necrolysis.
    Al-Mutairi N, Arun J, Osama NE, Amr Z, Mazen AS, Ibtesam el-A, Nazeha el-B.
    Int J Dermatol; 2004 Nov 20; 43(11):847-51. PubMed ID: 15533072
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 9.